1-(6-(6-Amino-4-(trifluoromethyl)pyridin-3-yl)-2-morpholinopyrimidin-4-yl)imidazolidin-2-one

ID: ALA5204344

Chembl Id: CHEMBL5204344

PubChem CID: 168293680

Max Phase: Preclinical

Molecular Formula: C17H18F3N7O2

Molecular Weight: 409.37

Names and Identifiers

Canonical SMILES:  Nc1cc(C(F)(F)F)c(-c2cc(N3CCNC3=O)nc(N3CCOCC3)n2)cn1

Standard InChI:  InChI=1S/C17H18F3N7O2/c18-17(19,20)11-7-13(21)23-9-10(11)12-8-14(27-2-1-22-16(27)28)25-15(24-12)26-3-5-29-6-4-26/h7-9H,1-6H2,(H2,21,23)(H,22,28)

Standard InChI Key:  WNXWURGDGPJBCM-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5204344

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 409.37

Molecular Weight (Monoisotopic): 409.1474

AlogP: 1.51

#Rotatable Bonds: 3

Polar Surface Area: 109.50

Molecular Species: NEUTRAL

HBA: 7

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 5.60

CX LogP: 1.49

CX LogD: 1.49

Aromatic Rings: 2

Heavy Atoms: 29

QED Weighted: 0.79

Np Likeness Score: -1.35

References

1. Fairhurst RA, Furet P, Imbach-Weese P, Stauffer F, Rueeger H, McCarthy C, Ripoche S, Oswald S, Arnaud B, Jary A, Maira M, Schnell C, Guthy DA, Wartmann M, Kiffe M, Desrayaud S, Blasco F, Widmer T, Seiler F, Gutmann S, Knapp M, Caravatti G..  (2022)  Identification of NVP-CLR457 as an Orally Bioavailable Non-CNS-Penetrant pan-Class IA Phosphoinositol-3-Kinase Inhibitor.,  65  (12.0): [PMID:35500094] [10.1021/acs.jmedchem.2c00267]

Source

Source(1):

• Scientific Literature